Screener
Ginkgo Bioworks DNA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Maturities of marketable debt securities | 166,168 | 64,958 |
| Purchases of property and equipment | (4,552) | (7,660) |
| Other | 48 | 262 |
| Net cash provided by (used in) investing activities | 34,219 | (262,572) |
| Cash flows from financing activities: | ||
| Proceeds from ATM offering | 17,049 | — |
| Payment of issuance costs related to ATM offering | (560) | — |
| Principal payments on finance leases | (19) | (305) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's investing cash flow?
- Ginkgo Bioworks (DNA) reported investing cash flow of $11.09M in Q2 2026.
- How has Ginkgo Bioworks's investing cash flow changed year-over-year?
- Ginkgo Bioworks's investing cash flow increased by 117.4% year-over-year, from -$63.89M to $11.09M.
- What is the long-term trend for Ginkgo Bioworks's investing cash flow?
- Over 2 years (2021 to 2024), Ginkgo Bioworks's investing cash flow has grown at a -10.4% compound annual growth rate (CAGR), from -$77.49M to -$62.24M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Ginkgo Bioworks's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude